Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

SELL
$72.36 - $113.1 $6.24 Million - $9.75 Million
-86,181 Reduced 57.31%
64,196 $4.65 Million
Q2 2022

Aug 03, 2022

SELL
$87.2 - $114.05 $4.92 Million - $6.44 Million
-56,458 Reduced 27.3%
150,377 $16.1 Million
Q1 2022

Apr 27, 2022

SELL
$94.19 - $124.49 $9,419 - $12,449
-100 Reduced 0.05%
206,835 $22.9 Million
Q4 2021

Feb 01, 2022

SELL
$119.57 - $139.07 $945,798 - $1.1 Million
-7,910 Reduced 3.68%
206,935 $26.5 Million
Q3 2021

Nov 03, 2021

SELL
$109.17 - $142.35 $21,834 - $28,470
-200 Reduced 0.09%
214,845 $28.6 Million
Q2 2021

Jul 30, 2021

SELL
$100.34 - $115.69 $524,276 - $604,480
-5,225 Reduced 2.37%
215,045 $23.3 Million
Q1 2021

Apr 30, 2021

BUY
$101.51 - $125.27 $3.26 Million - $4.02 Million
32,085 Added 17.05%
220,270 $23.2 Million
Q4 2020

Jan 29, 2021

SELL
$85.88 - $105.36 $1.19 Million - $1.46 Million
-13,825 Reduced 6.84%
188,185 $19.6 Million
Q3 2020

Oct 30, 2020

SELL
$72.74 - $92.5 $3.19 Million - $4.06 Million
-43,885 Reduced 17.85%
202,010 $17.3 Million
Q2 2020

Aug 03, 2020

BUY
$48.02 - $79.04 $3.33 Million - $5.48 Million
69,285 Added 39.23%
245,895 $18 Million
Q1 2020

Apr 30, 2020

SELL
$36.95 - $62.95 $227,796 - $388,086
-6,165 Reduced 3.37%
176,610 $9.18 Million
Q4 2019

Jan 31, 2020

SELL
$47.06 - $56.64 $596,485 - $717,912
-12,675 Reduced 6.49%
182,775 $10.3 Million
Q3 2019

Nov 04, 2019

SELL
$47.45 - $58.05 $3.56 Million - $4.35 Million
-74,985 Reduced 27.73%
195,450 $9.32 Million
Q2 2019

Jul 31, 2019

SELL
$39.26 - $54.21 $74,986 - $103,541
-1,910 Reduced 0.7%
270,435 $14.7 Million
Q1 2019

May 01, 2019

BUY
$29.84 - $43.92 $970,396 - $1.43 Million
32,520 Added 13.56%
272,345 $11.1 Million
Q4 2018

Jan 31, 2019

BUY
$29.95 - $46.34 $9,584 - $14,828
320 Added 0.13%
239,825 $7.48 Million
Q3 2018

Nov 13, 2018

SELL
$40.12 - $45.55 $1.91 Million - $2.16 Million
-47,500 Reduced 16.55%
239,505 $10.9 Million
Q2 2018

Aug 02, 2018

SELL
$38.72 - $42.52 $291,174 - $319,750
-7,520 Reduced 2.55%
287,005 $12 Million
Q1 2018

Apr 30, 2018

SELL
$39.4 - $47.39 $2.51 Million - $3.02 Million
-63,725 Reduced 17.79%
294,525 $12.1 Million
Q3 2017

Oct 31, 2017

BUY
$33.75 - $41.67 $12.1 Million - $14.9 Million
358,250
358,250 $14.3 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.